NYSEArca - Delayed Quote USD

Virtus LifeSci Biotech Products ETF (BBP)

52.39 +0.86 (+1.66%)
At close: April 23 at 3:59 PM EDT

Performance Overview: BBP

Trailing returns as of 4/22/2024. Category is Health.

YTD Return

BBP
11.29%
Category
6.33%

1-Year Return

BBP
0.63%
Category
11.04%

3-Year Return

BBP
1.23%
Category
0.38%

Trailing Returns (%) Vs. Benchmarks

Monthly Total Returns
BBP
Category
YTD
-2.20%
6.33%
1-Month
-4.85%
1.19%
3-Month
-2.20%
6.33%
1-Year
14.85%
11.04%
3-Year
2.69%
-0.38%
5-Year
4.84%
7.51%
10-Year
0.00%
9.04%
Last Bull Market
0.00%
0.00%
Last Bear Market
0.00%
0.00%

Annual Total Return (%) History

Year
BBP
Category
2023
17.88%
3.22%
2022
0.85%
-15.16%
2021
-8.17%
6.88%
2020
22.24%
27.63%
2019
24.73%
26.23%
2018
-13.95%
-0.40%
2017
24.07%
24.31%
2016
6.26%
-10.60%

2015
19.54%
8.05%

ETF Summary

Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with at least one drug therapy approved by the U.S. Food and Drug Administration ("FDA") for marketing.

ETF Overview

Category Health
Fund Family Virtus
Net Assets 19.84M
YTD Daily Total Return -11.29%
Yield 0.00%
Legal Type Exchange Traded Fund

Related Tickers